UNITED THERAPEUTICS Corp - Common Stock (UTHR)
CUSIP: 91307C102
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,833,193
- Total 13F shares
- 44,424,001
- Share change
- -620,045
- Total reported value
- $10,034,347,626
- Put/Call ratio
- 153%
- Price per share
- $225.87
- Number of holders
- 503
- Value change
- -$137,617,629
- Number of buys
- 239
- Number of sells
- 209
Quarterly Holders Quick Answers
What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 91307C102:
Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
12%
|
5,096,685
|
$1,125,093,216 | — | 30 Jun 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
11%
|
4,688,824
|
$1,035,057,899 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
4,642,538
|
$1,024,840,262 | — | 30 Jun 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.8%
|
2,909,999
|
$642,382,279 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
6.1%
|
2,616,356
|
$577,560,650 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
5.1%
|
2,187,214
|
$482,827,000 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
1,875,758
|
$414,073,579 | — | 30 Jun 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.1%
|
878,844
|
$194,014,004 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
806,381
|
$177,757,577 | — | 30 Jun 2023 | |
| Palo Alto Investors LP |
13F
|
Company |
1.5%
|
627,514
|
$138,523,716 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
596,230
|
$131,617,775 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
534,754
|
$118,045,236 | — | 30 Jun 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
510,601
|
$111,821,619 | — | 30 Jun 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.1%
|
488,183
|
$107,766,397 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
476,580
|
$105,205,035 | — | 30 Jun 2023 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
1%
|
432,420
|
$95,456,737 | — | 30 Jun 2023 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.96%
|
412,237
|
$91,001,292 | — | 30 Jun 2023 | |
| Swedbank AB |
13F
|
Company |
0.95%
|
405,302
|
$89,470,418 | — | 30 Jun 2023 | |
| NORGES BANK |
13F
|
Company |
0.95%
|
404,827
|
$89,365,560 | — | 30 Jun 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.94%
|
401,900
|
$88,719,425 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.93%
|
396,518
|
$87,531,350 | — | 30 Jun 2023 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.89%
|
379,368
|
$83,745,000 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.78%
|
334,624
|
$73,868,248 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
333,355
|
$73,588,116 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.72%
|
308,776
|
$68,162,522 | — | 30 Jun 2023 | |
| ASSETMARK, INC |
13F
|
Company |
0.66%
|
281,596
|
$62,162,317 | — | 30 Jun 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.63%
|
270,283
|
$59,665,000 | — | 30 Jun 2023 | |
| Eversept Partners, LP |
13F
|
Company |
0.61%
|
260,398
|
$57,482,859 | — | 30 Jun 2023 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.59%
|
254,664
|
$56,217,078 | — | 30 Jun 2023 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.57%
|
242,735
|
$53,583,751 | — | 30 Jun 2023 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.56%
|
238,388
|
$52,624,151 | — | 30 Jun 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.52%
|
224,557
|
$49,570,958 | — | 30 Jun 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.52%
|
221,539
|
$48,904,735 | — | 30 Jun 2023 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.5%
|
213,428
|
$47,114,231 | — | 30 Jun 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.49%
|
211,344
|
$46,654,188 | — | 30 Jun 2023 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
0.47%
|
202,715
|
$44,749,000 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.47%
|
202,153
|
$44,625,277 | — | 30 Jun 2023 | |
| Iron Triangle Partners LP |
13F
|
Company |
0.47%
|
200,000
|
$44,150,000 | — | 30 Jun 2023 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.46%
|
198,869
|
$43,900,330 | — | 30 Jun 2023 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.45%
|
193,267
|
$42,663,690 | — | 30 Jun 2023 | |
| Polaris Capital Management, LLC |
13F
|
Company |
0.45%
|
193,150
|
$42,637,863 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.44%
|
187,003
|
$41,280,913 | — | 30 Jun 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.42%
|
181,672
|
$40,104,095 | — | 30 Jun 2023 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.4%
|
172,926
|
$38,173,649 | — | 30 Jun 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.4%
|
172,301
|
$38,035,446 | — | 30 Jun 2023 | |
| Eagle Health Investments LP |
13F
|
Company |
0.4%
|
170,838
|
$37,712,489 | — | 30 Jun 2023 | |
| Swiss National Bank |
13F
|
Company |
0.39%
|
167,155
|
$36,899,466 | — | 30 Jun 2023 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.39%
|
165,069
|
$36,438,000 | — | 30 Jun 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.37%
|
157,678
|
$34,807,419 | — | 30 Jun 2023 | |
| TOBAM |
13F
|
Company |
0.35%
|
148,493
|
$32,780,000 | — | 30 Jun 2023 |
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2023
As of 30 Sep 2023,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
503 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,424,001 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, GEODE CAPITAL MANAGEMENT, LLC, and Palo Alto Investors LP.
This page lists
503
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
466
Q3 2023 holders
503
Holder diff
37
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.